Allarity Therapeutics, Inc. has announced a virtual Special Meeting of Stockholders to be held on a to-be-determined date in March 2024. The meeting will address two key proposals: a Reverse Stock Split Proposal and an Adjournment Proposal. The Reverse Stock Split Proposal, if approved, would allow the Board of Directors to effect a reverse stock split of the company's issued and outstanding common stock at a ratio between 1-for-5 and 1-for-20, at the Board's discretion. The Adjournment Proposal seeks approval to adjourn the meeting, if necessary, to solicit additional proxies in favor of the Reverse Stock Split Proposal. Stockholders as of February 21, 2024, are entitled to vote, with holders of Common Stock and Series A Convertible Preferred Stock...Show More

Allarity Therapeutics, Inc. has announced a virtual Special Meeting of Stockholders to be held on a to-be-determined date in March 2024. The meeting will address two key proposals: a Reverse Stock Split Proposal and an Adjournment Proposal. The Reverse Stock Split Proposal, if approved, would allow the Board of Directors to effect a reverse stock split of the company's issued and outstanding common stock at a ratio between 1-for-5 and 1-for-20, at the Board's discretion. The Adjournment Proposal seeks approval to adjourn the meeting, if necessary, to solicit additional proxies in favor of the Reverse Stock Split Proposal. Stockholders as of February 21, 2024, are entitled to vote, with holders of Common Stock and Series A Convertible Preferred Stock voting together on the proposals. The meeting is part of Allarity's efforts to comply with NASDAQ's minimum bid price requirements and to potentially increase marketability and liquidity of the company's stock. The Board and management emphasize the importance of stockholder votes at the Special Meeting, which will be conducted exclusively online via live audio webcast.